1 recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
Follow Receptors, Complement 3d: new trials by email Literature Review of Receptors, Complement 3d trials Research Report on Receptors, Complement 3d
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Chidamide, Lenalidomide, and Rituximab in Newly Diagnosed Elderly/unFit DE-DLBCL Chidamide in combination with Lenalidomide and Rituximab (CR2) - Double Expressor DLBCL, ELDERLY PEOPLE | Phase 2 | Recruiting | The First Affiliated Hospital with Nanjing Medical University | 38 | 2024-03-11 | 2026-10-20 |
The First Affiliated Hospital with Nanjing Medical University (1)
China (1)